(Q28174818)

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Preeclampsia: an excessive maternal inflammatory response to pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

TREATMENT OF ECLAMPSIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

The relation between life stress and hypertensive complications during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Dietary sodium restriction during pregnancy; a historical review

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

(Patho)physiological implications of chronic dietary sodium restriction during pregnancy; a longitudinal prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Sodium-blood pressure interrelationship in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low sodium diet and pregnancy-induced hypertension: a multi-centre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low-sodium diet in pregnancy: effects on blood pressure and maternal nutritional status

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Central hemodynamic observations in untreated preeclamptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Dietary sodium restriction in the prophylaxis of hypertensive disorders of pregnancy: effects on the intake of other nutrients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

The implications of hypozincemia in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Zinc supplementation during pregnancy: a double blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Zinc supplementation during pregnancy: a double blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Trial of calcium to prevent preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. FRACOG and the ACT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Oxidative stress and altered endothelial cell function in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Partners in defense, vitamin E and vitamin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Principles and applications of manipulation of prostaglandin synthesis in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

A randomised double blind placebo controlled trial of fish oil in high risk pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Attempts at dietary alteration of prostaglandin pathways in the management of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Treatment of hypertension in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Aspirin as an antiplatelet drug

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

The Use of Low Dose Aspirin in Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

The pharmacological prevention of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low-dose aspirin therapy to prevent preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Where next for prophylaxis against pre-eclampsia?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

A randomised trial of low dose aspirin for primiparae in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Multicentre trials in obstetrics and gynaecology. Smaller explanatory trials are required

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Proteinuria and its assessment in normal and hypertensive pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Administration time-dependent effects of aspirin in women at differing risk for preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Are pill counts valid measures of compliance in clinical obstetric trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Underestimation of the true benefits of antihypertensive treatment: an assessment of some important sources of error

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021

Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2800%2900303-1

7 January 2021